Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 256 AL 270

Metabolic profiling in the arena of gut-brain interaction studies for Alzheimer's disease

Olga D, Helen GG.

Bioanalysis. 2020 Apr;12(8):501-504. doi: 10.4155/bio-2020-0066. Epub 2020 Apr 30.

Calcium-activated potassium channels: implications for aging and age-related neurodegeneration

Trombetta-Lima M, Krabbendam IE, Dolga AM.

Int J Biochem Cell Biol. 2020 Jun;123:105748. doi: 10.1016/j.biocel.2020.105748. Epub 2020 Apr 27.

Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease

Uddin MS, Kabir MT, Mamun AA, Barreto GE, Rashid M, Perveen A, Ashraf GM.

Int Immunopharmacol. 2020 Jul;84:106479. doi: 10.1016/j.intimp.2020.106479. Epub 2020 Apr 27.

Successive cleavage of β-amyloid precursor protein by γ-secretase

Funamoto S, Tagami S, Okochi M, Morishima-Kawashima M.

Semin Cell Dev Biol. 2020 Sep;105:64-74. doi: 10.1016/j.semcdb.2020.04.002. Epub 2020 Apr 27.

The MUC6/AP2A2 Locus and Its Relevance to Alzheimer's Disease: A Review

Nelson PT, Fardo DW, Katsumata Y.

J Neuropathol Exp Neurol. 2020 Jun 1;79(6):568-584. doi: 10.1093/jnen/nlaa024.

Volume estimation of brain ventricles using Cavalieri's principle and Atlas-based methods in Alzheimer disease: Consistency between methods

Karaca O, Buyukmert A, Tepe N, Ozcan E, Kus I.

J Clin Neurosci. 2020 Aug;78:333-338. doi: 10.1016/j.jocn.2020.04.092. Epub 2020 Apr 29.

Tau immunotherapies: Lessons learned, current status and future considerations

Sandusky-Beltran LA, Sigurdsson EM.

Neuropharmacology. 2020 Sep 15;175:108104. doi: 10.1016/j.neuropharm.2020.108104. Epub 2020 Apr 28.

The current landscape in Alzheimer's disease research and drug discovery

Devenish SRA.

Drug Discov Today. 2020 Jun;25(6):943-945. doi: 10.1016/j.drudis.2020.04.002. Epub 2020 Apr 28.

Alzheimer's Disease and Functional Foods: An Insight on Neuroprotective Effect of its Combination

Hasnieza Mohd Rosli N, Mastura Yahya H, Shahar S, Wahida Ibrahim F, Fadilah Rajab N.

Pak J Biol Sci. 2020 Jan;23(5):575-589. doi: 10.3923/pjbs.2020.575.589.

Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease

Amponsah AE, Feng B, Guo R, Zhang W, He J, Kong D, Dong T, Ma J, Cui H.

Rev Neurosci. 2020 Aug 27;31(6):589-603. doi: 10.1515/revneuro-2019-0115.

Type 3 Diabetes and Its Role Implications in Alzheimer's Disease

Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV.

Int J Mol Sci. 2020 Apr 30;21(9):3165. doi: 10.3390/ijms21093165.

Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Int J Mol Sci. 2020 Apr 30;21(9):3186. doi: 10.3390/ijms21093186.

Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease

Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.

Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.

Epilepsy and Alzheimer's Disease: Potential mechanisms for an association

Giorgi FS, Saccaro LF, Busceti CL, Biagioni F, Fornai F.

Brain Res Bull. 2020 Jul;160:107-120. doi: 10.1016/j.brainresbull.2020.04.009. Epub 2020 May 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias